venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $555,056 (100.0% shares, 0.0% debt)

Holdings (9)

ALXO ALX ONCOLOGY HLDGS INC 37.6%

Value ($000) $208,451 Shares 9,699,925 Est. Cost $39.31 Unrealized +9.7%

HRMY HARMONY BIOSCIENCES HLDGS IN 21.1%

Value ($000) $116,851 Shares 2,740,411 Est. Cost $36.46 Unrealized +9.3%

VTYX VENTYX BIOSCIENCES INC 17.9%

Value ($000) $99,529 Shares 5,011,536 Est. Cost $18.95 Unrealized 0.0%

— AKERO THERAPEUTICS INC 8.3%

Value ($000) $45,931 Shares 2,171,664 Est. Cost $19.15 Unrealized —

PHVS PHARVARIS N V 6.0%

Value ($000) $33,145 Shares 2,303,310 Est. Cost $31.46 Unrealized -50.3%

— IMPEL NEUROPHARMA INC 4.3%

Value ($000) $23,817 Shares 2,759,791 Est. Cost $8.85 Unrealized —

— ELEVATION ONCOLOGY INC 2.8%

Value ($000) $15,701 Shares 2,608,167 Est. Cost $13.57 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 1.9%

Value ($000) $10,543 Shares 3,673,374 Est. Cost $11.51 Unrealized —

— VERONA PHARMA PLC 0.2%

Value ($000) $1,088 Shares 161,897 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$208,451	37.6%	$39.31	+9.7%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	2,740,411	$116,851	21.1%	$36.46	+9.3%	COM	413197104
VTYX	VENTYX BIOSCIENCES INC	5,011,536	$99,529	17.9%	$18.95	0.0%	COM	92332V107
—	AKERO THERAPEUTICS INC	2,171,664	$45,931	8.3%	$19.15	—	COM	00973Y108
PHVS	PHARVARIS N V	2,303,310	$33,145	6.0%	$31.46	-50.3%	COM	N69605108
—	IMPEL NEUROPHARMA INC	2,759,791	$23,817	4.3%	$8.85	—	COM	45258K109
—	ELEVATION ONCOLOGY INC	2,608,167	$15,701	2.8%	$13.57	—	COM	28623U101
—	CHECKMATE PHARMACEUTICALS IN	3,673,374	$10,543	1.9%	$11.51	—	COM	162818108
—	VERONA PHARMA PLC	161,897	$1,088	0.2%	$9.65	—	SPONSORED ADS	925050106